Healthcare
GeoVax Advances Toward European Approval for Mpox Vaccine Following EMA Guidance
GeoVax Labs, Inc. has received positive Scientific Advice from the European Medicines Agency, paving the way for expedited approval of its GEO-MVA Mpox vaccine in the EU, potentially accelerating revenue generation.
Skin, Bones, Hearts & Private Parts to Host Orlando CME Conference Offering Up to 39 Credits
The upcoming Orlando CME conference by Skin, Bones, Hearts & Private Parts offers healthcare professionals a chance to earn up to 39 CME credits across various specialties, emphasizing practical learning and relaxation.
Atlanta's Artemis Smiles Orthodontics Sets New Standards in Family-Oriented Care
Artemis Smiles Orthodontics in Atlanta is recognized for its innovative orthodontic solutions and family-oriented approach, offering personalized care with advanced technology.
Imagine Orthodontic Studio Earns Top Honors in Tampa Bay for 2024
Imagine Orthodontic Studio's recognition as one of Tampa Bay's Best Orthodontic Offices underscores its commitment to exceptional care and innovative treatments.
Creative Biolabs Advances Precision Medicine with Dual 3D Organoid and Tissue Slice Models
Creative Biolabs is enhancing precision medicine research by integrating 3D organoid and precision-cut tissue slice models, offering a more accurate and efficient approach to drug testing and disease modeling.
Study Reveals Early Health Visits May Predict Multiple Sclerosis Decades Before Diagnosis
A recent study indicates that individuals later diagnosed with multiple sclerosis visit healthcare providers more frequently decades before their diagnosis, suggesting potential for earlier intervention.
Soligenix Inc. Reports Promising Results in HyBryte(TM) Trial for Early-Stage Cutaneous T-Cell Lymphoma
Soligenix Inc.'s HyBryte(TM) shows promising treatment success in early-stage cutaneous T-cell lymphoma, offering hope for patients with limited options.
Nutriband Inc. Announces Key Dates for 25% Preferred Stock Dividend
Nutriband Inc. (NASDAQ: NTRB) has set important dates for its 25% preferred stock dividend, linking the dividend's value to the FDA approval of its AVERSA Fentanyl product, marking a significant milestone for shareholders and the company's growth in the pharmaceutical sector.
SeaStar Medical and AREVA Institute Collaborate on Innovative Burn Treatment Research with DoD Grant
A $2 million DoD grant supports SeaStar Medical and AREVA Institute's research into SCD therapy for reducing hyperinflammation in severe burns, potentially revolutionizing treatment for military and civilian patients.
ABVC BioPharma Achieves $100,000 Licensing Milestone with ForSeeCon, Enhancing Ophthalmology Focus
ABVC BioPharma's recent $100,000 milestone payment from ForSeeCon Eye Corporation underscores the growing commercial interest in its ophthalmology solutions, particularly Vitargus®, and strengthens its position in the global eye care market.
KidzCare Pediatrics Expands Services in North Carolina with Oceanside Pediatrics Merger
KidzCare Pediatrics enhances pediatric healthcare in North Carolina by integrating Oceanside Pediatrics, broadening access to specialized services and strengthening community healthcare ties.
Study Links Heart Scar Tissue to Dangerous Rhythms in Older Male Athletes
A U.K. study finds scar tissue in the heart may increase the risk of dangerous heart rhythms in healthy, long-time male endurance athletes over 50, highlighting the importance of monitoring and safety measures in sports.
Understanding Chronic Venous Insufficiency: Implications Following President Trump's Diagnosis
The diagnosis of Chronic Venous Insufficiency (CVI) in President Donald J. Trump highlights the condition's prevalence and its association with increased cardiovascular risks, underscoring the importance of awareness and early treatment.
Fifty 1 Labs and UAV Corp Announce Strategic Partnership to Acquire BioSpark AI for Drug Repurposing Advancements
Fifty 1 Labs, Inc. and UAV Corp have announced a strategic partnership and intent to acquire BioSpark AI Technologies Inc., aiming to revolutionize drug repurposing through AI and large language model technologies.
Lantern Pharma Unveils AI Module to Enhance Cancer Combination Therapies Development
Lantern Pharma introduces an AI-powered module to streamline the creation of targeted cancer combination therapies, promising to cut development time and costs significantly.
Study Reveals Significant Proportion of Lung Cancer Patients Are Non-Smokers
Recent research highlights the puzzling prevalence of lung cancer among non-smokers, prompting urgent calls for further study and treatment development.
Notify to Introduce Nurse Call Standardization Technology at FALA 2025
Notify's participation at the FALA 2025 conference highlights its innovative solution to standardize fragmented nurse call systems in senior living communities, aiming to enhance caregiver efficiency and resident care.
Nashville Concierge Medicines Introduces Gender-Specific Health Resources
Nashville Concierge Medicines launches dedicated web pages for men and women, highlighting the benefits of concierge medical care tailored to gender-specific health needs.
Ritenour Counseling Expands Team with New Associate Marriage and Family Therapist
Mike Drasin joins Ritenour Counseling as an Associate Marriage and Family Therapist, bringing specialized skills in couples and family therapy to enhance the practice's services in San Ramon and surrounding communities.
Emerald Coast Heart & AFib Expands to Fort Walton Beach, Enhancing Cardiac Rhythm Care Access
Emerald Coast Heart & AFib's expansion into Fort Walton Beach marks a significant advancement in specialized cardiac rhythm care for Northwest Florida, offering cutting-edge treatments and patient education under Dr. Ian Weisberg's leadership.
Dr. Jeremy Saul Establishes Scholarship to Foster Future Healthcare Leaders
Dr. Jeremy Saul launches a $1,000 scholarship to support undergraduate students pursuing careers in healthcare, emphasizing compassion and community service.
MedSynergy Communications Launches to Bridge Health Tourism Gaps Between U.S. and Mexico
Fanny Miller and Esperanza Colin introduce MedSynergy Communications, a bilingual agency aimed at enhancing health tourism marketing and business structuring for healthcare providers targeting the U.S.-Mexico market.
FDA Grants RMAT Designation to GNSC-001 for Knee Osteoarthritis Treatment
The FDA's RMAT designation for GNSC-001 highlights its potential as a groundbreaking gene therapy for knee osteoarthritis, offering long-term relief with a single injection.
Mikaya Heart Introduces Monthly Zoom Series "The Art of Being Fully Alive" to Global Audience
Spiritual mentor Mikaya Heart expands access to her transformative course, offering individuals worldwide the opportunity to engage in deep emotional healing and energetic recalibration through a monthly Zoom series.
Woofie’s and American Kennel Club Collaborate to Enhance Dog Grooming Safety Nationwide
Woofie’s partnership with the American Kennel Club aims to standardize grooming safety training and certifications across its franchises, ensuring higher care standards for pets.
Lantern Pharma Engages IBN for Corporate Communications Strategy Amid AI-Driven Oncology Pipeline Advancements
Lantern Pharma partners with IBN to enhance investor awareness as it progresses its AI-driven oncology pipeline, including therapies for lung, brain, breast, and blood cancers.
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
A recent study indicates that a genetically altered herpes virus could offer a new treatment avenue for advanced melanoma, highlighting the potential of oncolytic viruses in cancer therapy.
BioAdaptives, Inc. Announces National Launch of NeuroRush(TM) Nootropic in 2025
BioAdaptives, Inc. is set to launch NeuroRush(TM), a nootropic designed to enhance cognitive functions, marking a significant step in the wellness industry's focus on brain health.
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials
Oragenics Inc. has partnered with Sterling Pharma Solutions for the GMP production of its concussion drug candidate, ONP-002, marking a significant step towards Phase IIb trials and underscoring the importance of domestic manufacturing in clinical development.
NanoViricides Advances MPox Treatment Amid WHO's Extended Health Emergency
NanoViricides, Inc. progresses with NV-387, a broad-spectrum antiviral drug, as the WHO extends the MPox global health emergency, highlighting the drug's potential to fill gaps in current treatments.